Phase XV, group 2 - 01.09.2024 - 30.08.2027

Ca.-No 218

Highly parallel identifikation of novel integration sites for CAR sequences

Israeli Partner: Eric Shifrut, Tel Aviv University
German Partner: Franziska Blaeschke, DKFZ

Publications

No publications available.

Ca.-No 219

Characterization of the molecular mechanisms underlying epigenomic aberrations in 1DH1-mutant malignancies

Israeli Partner: Efrat Shema, Weizmann Institute
German Partner: Daniel Lipka, DKFZ & NCT

Publications

2025 - Cell reports / Medicine

Erez, N. ; Furth, N. ; Fedyuk, V. ; Wadden, J. ; Aittaleb, R. ; Adam, T. ; Schwark, K. ; Niculcea, M. ; Miclea, M. ; Mody, R. ; Franson, A. ; Parmar, H. A. ; Ibrahim, M. ; Lau, B. ; Eze, A. ; Nourmohammadi, N. ; Fried, I. ; Nazarian, J. ; Ron, G. ; Venneti, S. ; Koschmann, C. ; Shema, E.

Ca.-No 220

Metaplastic transitions in liver and pancreas and their relationships with oncogenesis

Israeli Partner: Eli Pikarsky, Hebrew University
German Partner: Ana Martin-Villalba, DKFZ

Publications

No publications available.

Ca.-No 221

Soft micro-robots for active propulsion through tumor tissues

Israeli Partner: Alexander Leshansky, Technion
German Partner: Tian Qiu, DKFZ

Publications

2025 - Advanced intelligent systems

Jeong, M. ; Tian, J. ; Zhang, M. ; Qiu, T.

Ca.-No 222

Predicting clinical response to PD-based mono/combined immunotherapy of melanoma

Israeli Partner: Angel Porgador, Ben-Gurion University
German Partner: Jessica C. Hassel, University Hospital Heidelberg

Publications

2025 - International journal of molecular sciences

Yassin, A. A. ; Banerji, R. ; Bhattacharya, B. ; Radinsky, O. ; Hadad, U. ; Kaufman, B. ; Porgador, A.

2025 - Molecular cancer

Kaufman, B. ; Abu-Ahmad, M. ; Radinsky, O. ; Gharra, E. ; Manko, T. ; Bhattacharya, B. ; Gologan, D. ; Erlichman, N. ; Meshel, T. ; Nuta, Y. ; Cooks, T. ; Elkabets, M. ; Ben-Baruch, A. ; Porgador, A.

2024 - Journal of experimental & clinical cancer research

Novoplansky, O. ; Jagadeeshan, S. ; Prasad, M. ; Yegodayev, K. M. ; Marripati, D. ; Shareb, R. A. ; Greenshpan, Y. ; Mathukkada, S. ; Ben-Lulu, T. ; Bhattacharya, B. ; Porgador, A. ; Kong, D. ; Brägelmann, J. ; Gutkind, J. S. ; Elkabets, M.

Ca.-No 223

Targeting subcellular transport of MAP-kinasis against cancer therapy resistance

Israeli Partner: Rony Seger, Weizmann Institute
German Partner: Johannes Betge, DKFZ, Elke Burgermeister, University Hospital Mannheim

Publications

No publications available.

Ca.-No 224

Targeting the N1-methyladenosine (m1A) RNA modification in AML

Israeli Partner: Schraga Schwartz, Weizmann Institute
German Partner: Michaela Frye, DKFZ

Publications

No publications available.

Ca.-No 225

Developing Cysteine-Engineered Bispecific Anti-GD2 Chimeric Antigen Receptor-T Approach for Triple Negative Breast Cancer Therapy

Israeli Partner: Oren Moscovitz, Reichman University
German Partner: Christian Seitz, DKFZ

Publications

No publications available.

Ca.-No 226

Non-histone methylation pathways in epigenetic control of bladder cancer

Israeli Partner: Dan Levy, Ben-Gurion University
German Partner: Marc Timmers, University Hospital Freiburg

Publications

No publications available.

Ca.-No 227

Mapping Cancer-Specific DNA Breaks Under Replication Stress

Israeli Partner: Rami Aqeilan, Hebrew University
German Partner: Pei-Chi Wei, DKFZ

Publications

No publications available.

Ca.-No 228

Enhancing anti-cancer immunity in pediatric solid tumors via epitranscriptomic inhibition - high-risk neuroblastoma as a proof of concept

Israeli Partner: Liron Grossmann, Sheba Medical Center
German Partner: Frank Westermann, DKFZ

Publications

No publications available.

Ca.-No 229

The Role of CD4 T Cells in KRAS Mutated Solid Tumors Towards T Cell Receptor Gene Therapy

Israeli Partner: Jonathan Arnon, Hadassah University
German Partner: Gerald Willimsky, Charité Berlin

Publications

No publications available.

Formular

Formulardaten werden geladen ...